Information technologySoon-Shiong's NantHealth reports $184 million loss for 2016 | STAT
Dr. Patrick Soon-Shiong's diagnostics company, NantHealth, on Thursday reported that it had lost $184 million last year as the company's signature GPS Cancer diagnostic test struggled to gain traction.
PharmaceuticalsFDA nominee, paid millions by industry, says he'll rescue himself if needed | The New York Times
President Trump has repeatedly slammed pharmaceutical companies for “getting away with murder” on soaring drug prices, but he and his nominee to head the Food and Drug Administration have pledged to ease industry regulations and speed approvals for medicines and other consumer products.
FDA approves first drug to treat severe multiple sclerosis | The New York Times
The Food and Drug Administration approved on Tuesday the first drug to treat a severe form of multiple sclerosis, offering hope to patients who previously had no other options to combat a relentless disease that leads to paralysis and cognitive decline.
In a high-stakes battle between drug makers and insurers, last week it was the drug makers who got a lift, on a little-noticed issue and in an unusual place: Arkansas.
Safety, quality and clinical practiceWorkers who give care to the homebound often can't afford to get their own | Kaiser Health News
For more than two decades, Celeste Thompson, 57, a home care worker in Missoula, Mont., had not had regular contact with a doctor — no annual physicals and limited sick visits. She also needed new glasses.